A phase II study of Carboplatin plus Pemetrexed plus Atezolizumab plus Bevacizumab in chemotherapy and immunotherapy-naïve patients with stage IV non-squamous non-small cell lung cancer:
Big Ten Cancer Research Consortium BTCRC-LUN17-139

IRB/UVA Tracking #
21757
Contact
Gracie Hockenberry
Contact Email
Contact Phone
1.434.297.7784
Phase
II
Primary purpose
Treatment
Cancer PI
Ryan Gentzler
Status
OPEN TO ACCRUAL
Ages
Adult